Events & Presentations

Events & Presentations

Date Event Details Remind Me
Sep 26, 2018 from 2:00 PM to 5:30 PM CEST
Genmab's Capital Markets Day, Utrecht, The Netherlands
Genmab's Capital Markets Day will be held on Wednesday, 26 September at 14.00 CEST (08.00 EDT / 13.00 BST) at Genmab's new R&D Center in Utrecht, the Netherlands. The event will be webcast live. 
Nov 14, 2018 after 5:00 PM CET
Publication of the Interim Report for the first nine months 2018
Date Event Details
Sep 12, 2018 from 2:15 PM to 2:45 PM EDT
Morgan Stanley Global Healthcare Conference, New York, US
Sep 12 - Sep 14, 2018
Bank of America Merrill Lynch Global Healthcare Conference 2018, London, UK
Aug 9, 2018 after 3:00 PM CEST
Interactive Q&A Session with Genmab's CEO
Aug 8, 2018 after 6:00 PM CEST
First Half 2018 Conference Call
Aug 8, 2018 after 5:00 PM CEST
Publication of the Interim Report for the first half 2018
Jun 19 - Jun 20, 2018
Citi 2018 European Healthcare Conference, London, UK
Jun 14 - Jun 17, 2018
23rd Congress of EHA, Stockholm, Sweden
Please see our download library for links to abstracts. 
Jun 12, 2018 after 4:00 PM PDT
Goldman Sachs 39th Annual Global Healthcare Conference, Rancho Palos Verdes, CA, US
Genmab President & CEO, Jan van de Winkel, Ph.D., will present a company update at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, California at 4:00 PM PDT on June 12, 2018 (1:00 AM CEST on June 13, 2018). 
Jun 1 - Jun 5, 2018
ASCO Annual Meeting, Chicago, IL, US
Please see our download library for links to abstracts. 
May 21 - May 23, 2018
UBS Global Healthcare Conference, New York, NY, US
May 9, 2018 after 5:00 PM CEST
Interactive Q&A Session with Genmab's CEO
May 9, 2018
Deutsche Bank's 43rd Annual Healthcare Conference, Boston, MA, US
May 8, 2018 after 6:00 PM CEST
First Quarter 2018 Conference Call
Apr 18, 2018
Kempen Life Sciences Conference, Amsterdam, The Netherlands
Apr 10, 2018
Annual General Meeting 2018
Feb 27, 2018
Credit Suisse Healthcare Conference, London, UK
Feb 26, 2018
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Feb 22, 2018 after 4:00 PM CET
Interactive Q&A Session with Genmab's CEO
Feb 21, 2018 after 5:00 PM CET
Publication of the Annual Report for 2017
Jan 10, 2018 after 2:00 PM CET
36th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US
CEO, Jan van de Winkel, Ph.D., will present a company update at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 2:00 PM PST on January 10, 2018 (11:00 PM CET).